Tumor Lysate Particle Only Vaccine (TLPO) vs. Tumor Lysate Particle-Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in Resected Stage III/IV Melanoma Patients: Results of a Phase I/IIa TrialSpencer G. Van Decar,Elizabeth L. Carpenter,Alexandra M. Adams,Robert C. Chick,Guy T. Clifton,Alex Stojadinovic,Timothy J. Vreeland,Franklin A. Valdera,Ankur Tiwari,Anne E. O’Shea,Patrick M. McCarthy,Diane F. Hale,Phillip M Kemp Bohan,Annelies T. Hickerson,Jessica L. Cindass,John Hyngstrom,Adam C. Berger,James W. Jakub,Jeffrey J. Sussman,Montaser Shaheen,Xianzhong Yu,Thomas Wagner,Mark Faries,George Peoplescrossref（2024）引用 0|浏览40AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
